Medicine
Methenamine 1 g tablet
Methenamine 1 g tablet is a generic prescription medicine for oral use, made by 12 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Methenamine
- Brand
- Sold under the generic name
- Strength
- 1 g
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 20 tablets, 80 tablets and 11 more
- Manufacturers
- Jubilant Cadista PharmaceuticalsIndiaMicro LabsIndiaAurobindo PharmaIndiaViona PharmaceuticalsIndiaZydus LifesciencesIndiaAlvogenAmerican Health PackagingANI PharmaceuticalsAvPAKGolden State Medical Supply
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01XX05 Methenamine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 3 May 2010
- Identifiers
- RxCUI 992150DailyMed set ID 3c9e5bea-f61d-48c3-8e05-640eccccf2ba, 131a1322-0182-7a4e-e063-6394a90accbf, 4263d826-7de2-4011-b8ec-ba1f5222f0e6 +9NDC 72603-816, 51407-880, 59746-797 +9Application ANDA205661, ANDA210068, ANDA217675 +4
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 65862-782-01 | Aurobindo PharmaIndia | 5 July 2016 |
| 100 tablet in 1 bottle | 59746-797-01 | Jubilant Cadista PharmaceuticalsIndia | 24 January 2023 |
| 20 tablet in 1 bottle | 59746-797-65 | Jubilant Cadista PharmaceuticalsIndia | 24 January 2023 |
| 100 tablet in 1 bottle | 42571-332-01 | Micro LabsIndia | 15 August 2019 |
| 80 tablet in 1 carton | 42571-332-23 | Micro LabsIndia | 15 August 2019 |
| 100 tablet in 1 bottle | 72578-175-01 | Viona PharmaceuticalsIndia | 12 March 2025 |
| 100 tablet in 1 bottle | 70771-1919-1 | Zydus LifesciencesIndia | 12 March 2025 |
| 100 tablet in 1 bottle | 47781-577-01 | Alvogen | 23 October 2017 |
| 100 tablet in 1 bottle | 70954-959-10 | ANI Pharmaceuticals | 27 July 2026 |
| 100 tablet in 1 bottle | 50742-142-01 | Ingenus Pharmaceuticals | 18 December 2020 |
| 30 blister pack in 1 carton / 1 tablet in 1 blister pack | 60687-694-21 | American Health Packaging | 12 August 2022 |
| 50 blister pack in 1 carton / 1 tablet in 1 blister pack | 50268-549-15 | AvPAK | 2 December 2020 |
| 100 tablet in 1 bottle | 51407-880-01 | Golden State Medical Supply | 30 January 2024 |
| 100 tablet in 1 bottle | 72603-816-01 | NorthStar Rx | 1 April 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 5 July 1967 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Methenamine is a prescription medicine indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections when long-term therapy is considered necessary. It is available as tablets for oral use. MedsAcross supplies Methenamine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MethenamineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Methenamine Hippurate prescribing information (Alvogen) · U.S. National Library of Medicine, DailyMed
Need Methenamine 1 g tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.